Saturday 31 October 2009

Menorox




Menorox may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Menorox



Norfloxacin

Norfloxacin is reported as an ingredient of Menorox in the following countries:


  • South Africa

International Drug Name Search

Tuesday 27 October 2009

BroveX PSE


Generic Name: brompheniramine and pseudoephedrine (BROM fen EER a meen and SOO doe ed FED rin)

Brand Names: Andehist NR Syrup, Bidhist-D, Bromaline, Bromhist Pediatric Drops, Bromhist-NR, BroveX PD, BroveX PSE, Brovex SR, Di-Bromm, Histex SR, J-TanD PD, Lodrane 12D, Lodrane 24D, Lodrane D, Lodrane Liquid, LoHist-12D, LoHist-PD, Q-Tapp, Sildec, Touro Allergy, Ultrabrom, Ultrabrom PD


What is BroveX PSE (brompheniramine and pseudoephedrine)?

Brompheniramine is an antihistamine that reduces the natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose.


Pseudoephedrine is a decongestant that shrinks blood vessels in the nasal passages. Dilated blood vessels can cause nasal congestion (stuffy nose).


The combination of brompheniramine and pseudoephedrine is used to treat sneezing, cough, runny or stuffy nose, itchy or watery eyes, hives, skin rash, itching, and other symptoms of allergies and the common cold.


Brompheniramine and pseudoephedrine may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about BroveX PSE (brompheniramine and pseudoephedrine)?


There are many brands and forms of this medicine available and not all brands are listed on this leaflet.


Do not give this medication to a child younger than 2 years old. Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children. Do not use any other over-the-counter cold, allergy, or sleep medication without first asking your doctor or pharmacist. If you take certain products together you may accidentally take too much of a certain drug. Read the label of any other medicine you are using to see if it contains an antihistamine or decongestant. Do not use a cough or cold medicine if you have used an MAO inhibitor such as isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam), or tranylcypromine (Parnate) within the past 14 days. Serious, life-threatening side effects can occur if you take cough or cold medicine before the MAO inhibitor has cleared from your body. Brompheniramine and pseudoephedrine can cause side effects that may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be awake and alert. Avoid drinking alcohol. It can increase some of the side effects of this medication.

What should I discuss with my healthcare provider before taking BroveX PSE (brompheniramine and pseudoephedrine)?


Do not use a cough or cold medicine if you have used an MAO inhibitor such as isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam), or tranylcypromine (Parnate) within the past 14 days. Serious, life-threatening side effects can occur if you take cough or cold medicine before the MAO inhibitor has cleared from your body.

Ask a doctor or pharmacist if it is safe for you to take brompheniramine and pseudoephedrine if you have:


  • kidney disease;


  • diabetes;




  • glaucoma;




  • heart disease or high blood pressure;




  • diabetes;




  • a thyroid disorder;




  • an enlarged prostate; or




  • problems with urination.




This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. Brompheniramine and pseudoephedrine can pass into breast milk and may harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

Artificially-sweetened liquid forms of cold medicine may contain phenylalanine. This would be important to know if you have phenylketonuria (PKU). Check the ingredients and warnings on the medication label if you are concerned about phenylalanine.


How should I take BroveX PSE (brompheniramine and pseudoephedrine)?


Use this medication exactly as directed on the label, or as it has been prescribed by your doctor. Do not use the medication in larger amounts, or use it for longer than recommended. Cold medicine is usually taken only for a short time until your symptoms clear up.


Do not give this medication to a child younger than 2 years old. Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children. Take this medicine with a full glass of water. Do not crush, chew, or break an extended-release tablet. Swallow the pill whole. It is specially made to release medicine slowly in the body. Breaking or opening the pill would cause too much of the drug to be released at one time.

Measure the liquid form of this medicine with a special dose-measuring spoon or cup, not a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.


Talk with your doctor if your symptoms do not improve after 7 days of treatment, or if you have a fever with a headache, cough, or skin rash.

If you need to have any type of surgery, tell the surgeon ahead of time if you have taken a cold medicine within the past few days.


This medication can cause you to have unusual results with allergy skin tests. Tell any doctor who treats you that you are taking an antihistamine.


Store the medication at room temperature away from moisture and heat.

What happens if I miss a dose?


Since cold or allergy medicine is usually taken only as needed, you may not be on a dosing schedule. If you are taking the medication regularly, take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the medicine at your next regularly scheduled time. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine.

Overdose symptoms may include feeling restless or nervous, nausea, vomiting, stomach pain, dizziness, drowsiness, dry mouth, warmth or tingly feeling, or seizure (convulsions).


What should I avoid while taking BroveX PSE (brompheniramine and pseudoephedrine)?


This medication can cause side effects that may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be awake and alert. Avoid drinking alcohol. It can increase some of the side effects of this medication.

Avoid taking diet pills, caffeine pills, or other stimulants (such as ADHD medications) without your doctor's advice. Taking a stimulant together with a decongestant can increase your risk of unpleasant side effects.


Do not use any other over-the-counter cold, allergy, or sleep medication without first asking your doctor or pharmacist. If you take certain products together you may accidentally take too much of a certain drug. Read the label of any other medicine you are using to see if it contains an antihistamine or decongestant.

BroveX PSE (brompheniramine and pseudoephedrine) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using this medication and call your doctor at once if you have any of these serious side effects:

  • fast, pounding, or uneven heartbeat;




  • confusion, hallucinations, unusual thoughts or behavior;




  • severe dizziness, anxiety, restless feeling, or nervousness;




  • increased blood pressure (severe headache, blurred vision, trouble concentrating, chest pain, numbness, seizure);




  • confusion, hallucinations, unusual thoughts or behavior;




  • easy bruising or bleeding, unusual weakness, fever, chills, body aches, flu symptoms; or




  • urinating less than usual or not at all.



Less serious side effects may include:



  • blurred vision;




  • dry mouth;




  • nausea, stomach pain, constipation;




  • mild loss of appetite, stomach upset;




  • warmth, tingling, or redness under your skin;




  • sleep problems (insomnia);




  • restless or excitability (especially in children);




  • skin rash or itching;




  • dizziness, drowsiness;




  • problems with memory or concentration; or




  • ringing in your ears.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect BroveX PSE (brompheniramine and pseudoephedrine)?


Sedatives, narcotic pain medicine, sleeping pills, muscle relaxers, and medicine for seizures, depression or anxiety can add to sleepiness caused by brompheniramine. Tell your doctor if you regularly use any of these medicines, or any other cold or allergy medications..

Tell your doctor about all other medications you use, especially:



  • medicines to treat high blood pressure;




  • a diuretic (water pill);




  • medication to treat irritable bowel syndrome;




  • bladder or urinary medications such as oxybutynin (Ditropan, Oxytrol) or tolterodine (Detrol);




  • aspirin or salicylates (such as Disalcid, Doan's Pills, Dolobid, Salflex, Tricosal, and others);




  • a beta-blocker such as atenolol (Tenormin), carteolol (Cartrol), metoprolol (Lopressor, Toprol), nadolol (Corgard), propranolol (Inderal), sotalol (Betapace), timolol (Blocadren), and others; or




  • antidepressants such as amitriptyline (Elavil), clomipramine (Anafranil), imipramine (Janimine, Tofranil), and others.



This list is not complete and there may be other drugs that can interact with brompheniramine and pseudoephedrine. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.



More BroveX PSE resources


  • BroveX PSE Side Effects (in more detail)
  • BroveX PSE Use in Pregnancy & Breastfeeding
  • BroveX PSE Drug Interactions
  • BroveX PSE Support Group
  • 0 Reviews for BroveX PSE - Add your own review/rating


  • Bidhist-D Sustained-Release Tablets MedFacts Consumer Leaflet (Wolters Kluwer)

  • Bromfenex Controlled-Release and Sustained-Release Capsules MedFacts Consumer Leaflet (Wolters Kluwer)

  • Lodrane D MedFacts Consumer Leaflet (Wolters Kluwer)



Compare BroveX PSE with other medications


  • Hay Fever
  • Nasal Congestion


Where can I get more information?


  • Your pharmacist can provide more information about brompheniramine and pseudoephedrine.

See also: BroveX PSE side effects (in more detail)


Monday 26 October 2009

Optisulin




Optisulin may be available in the countries listed below.


Ingredient matches for Optisulin



Insulin Glargine

Insulin Glargine is reported as an ingredient of Optisulin in the following countries:


  • Slovakia

International Drug Name Search

Friday 23 October 2009

Acébutolol Mylan




Acébutolol Mylan may be available in the countries listed below.


Ingredient matches for Acébutolol Mylan



Acebutolol

Acebutolol is reported as an ingredient of Acébutolol Mylan in the following countries:


  • Tunisia

Acebutolol hydrochloride (a derivative of Acebutolol) is reported as an ingredient of Acébutolol Mylan in the following countries:


  • France

International Drug Name Search

Simvastatina Pliva




Simvastatina Pliva may be available in the countries listed below.


Ingredient matches for Simvastatina Pliva



Simvastatin

Simvastatin is reported as an ingredient of Simvastatina Pliva in the following countries:


  • Italy

  • Spain

International Drug Name Search

Pulmonary Edema Medications


Definition of Pulmonary Edema: Pulmonary edema involves fluid accumulation and swelling in the lungs.

Drugs associated with Pulmonary Edema

The following drugs and medications are in some way related to, or used in the treatment of Pulmonary Edema. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Pulmonary Edema





Drug List:

Monday 19 October 2009

Melfiat




In the US, Melfiat (phendimetrazine systemic) is a member of the following drug classes: anorexiants, CNS stimulants and is used to treat Obesity.

US matches:

  • Melfiat

Ingredient matches for Melfiat



Phendimetrazine

Phendimetrazine tartrate (a derivative of Phendimetrazine) is reported as an ingredient of Melfiat in the following countries:


  • United States

International Drug Name Search

Sunday 18 October 2009

Ciclochem




Ciclochem may be available in the countries listed below.


Ingredient matches for Ciclochem



Ciclopirox

Ciclopirox olamine (a derivative of Ciclopirox) is reported as an ingredient of Ciclochem in the following countries:


  • Spain

International Drug Name Search

Sunday 11 October 2009

Topex




In the US, Topex (benzocaine topical) is a member of the drug class topical anesthetics and is used to treat Oral and Dental Conditions.

US matches:

  • Topex

  • Topex Gel

Ingredient matches for Topex



Benzocaine

Benzocaine is reported as an ingredient of Topex in the following countries:


  • United States

International Drug Name Search

Thursday 8 October 2009

Domperidone Mylan




Domperidone Mylan may be available in the countries listed below.


Ingredient matches for Domperidone Mylan



Domperidone

Domperidone is reported as an ingredient of Domperidone Mylan in the following countries:


  • Italy

International Drug Name Search

Sustiva


Sustiva is a brand name of efavirenz, approved by the FDA in the following formulation(s):


SUSTIVA (efavirenz - capsule; oral)



  • Manufacturer: BRISTOL MYERS SQUIBB

    Approval date: September 17, 1998

    Strength(s): 200MG [RLD], 50MG

SUSTIVA (efavirenz - tablet; oral)



  • Manufacturer: BRISTOL MYERS SQUIBB

    Approval date: February 1, 2002

    Strength(s): 600MG [RLD]

Has a generic version of Sustiva been approved?


No. There is currently no therapeutically equivalent version of Sustiva available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Sustiva. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Benzoxazinones as inhibitors of HIV reverse transcriptase
    Patent 5,519,021
    Issued: May 21, 1996
    Inventor(s): Young; Steven D. & Britcher; Susan F. & Payne; Linda S. & Tran; Lekhanh O. & Lumma, Jr.; William C.
    Assignee(s): Merck & Co., Inc.
    Certain benzoxazinones are useful in the inhibition of HIV reverse transcriptase (including its resistant varieties), the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
    Patent expiration dates:

    • May 21, 2013
      ✓ 
      Drug substance
      ✓ 
      Drug product


    • May 21, 2013




  • Benzoxazinones as inhibitors of HIV reverse transcriptase
    Patent 5,663,169
    Issued: September 2, 1997
    Inventor(s): Young; Steven D. & Payne; Linda S. & Britcher; Susan F. & Tran; Lekhanh O. & Lumma, Jr.; William C.
    Assignee(s): Merck & Co., Inc.
    Certain benzoxazinones are useful in the inhibition of HIV reverse transcriptase (including its resistant varieties), the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable saks, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
    Patent expiration dates:

    • September 2, 2014
      ✓ 
      Patent use: TREATMENT OF HIV INFECTION


    • September 2, 2014


    • September 2, 2014
      ✓ 
      Patent use: TREATMENT OF HIV




  • Benzoxazinones as inhibitors of HIV reverse transcriptase
    Patent 5,811,423
    Issued: September 22, 1998
    Inventor(s): Young; Steven D. & Payne; Linda S. & Britcher; Susan F. & Tran; Lekhanh O. & Lumma, Jr.; William C.
    Assignee(s): Merck & Co., Inc.
    Certain benzoxazinones are useful in the inhibition of HIV reverse transcriptase (including its resistant varieties), the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
    Patent expiration dates:

    • August 7, 2012
      ✓ 
      Patent use: TREATMENT OF HIV INFECTION IN COMBINATION WITH ONE OR MORE ADDITIONAL HIV ANTIVIRAL AGENTS
      ✓ 
      Drug substance
      ✓ 
      Drug product


    • August 7, 2012
      ✓ 
      Patent use: TREATMENT OF HIV INFECTION IN COMBINATION WITH ONE OR MORE ADDITIONAL HIV ANTIVIRAL AGENTS




  • Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
    Patent 6,238,695
    Issued: May 29, 2001
    Inventor(s): Makooi-Morehead; William T. & Buehler; John D. & Landmann; Brian R.
    Assignee(s): DuPont Pharmaceuticals Company
    The present invention provides improved oral dosage form formulations of efavirenz that are useful in the inhibition of human immunodeficiency virus (HIV), the prevention or treatment of infection by HIV, and in the treatment of the resulting acquired immune deficiency syndrome (AIDS). In particular, the present invention relates to compressed tablets or capsules comprising efavirenz that contain one or more disintegrants that enhance the dissolution rate of the efavirenz in the gastrointestinal tract thereby improving the rate and extent of absorption of efavirenz in the body. The present invention also relates to the process of making such tablets or capsules.
    Patent expiration dates:

    • April 6, 2019
      ✓ 
      Drug product




  • Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
    Patent 6,555,133
    Issued: April 29, 2003
    Inventor(s): William T.; Makooi-Morehead & John D.; Buehler & Brian R.; Landmann
    Assignee(s): Bristol-Myers Squibb Company
    The present invention provides improved oral dosage form formulations of efavirenz that are useful in the inhibition of human immunodeficiency virus (HIV), the prevention or treatment of infection by HIV, and in the treatment of the resulting acquired immune deficiency syndrome (AIDS). In particular, the present invention relates to compressed tablets or capsules comprising efavirenz that contain one or more disintegrants that enhance the dissolution rate of the efavirenz in the gastrointestinal tract thereby improving the rate and extent of absorption of efavirenz in the body. The present invention also relates to the process of making such tablets or capsules.
    Patent expiration dates:

    • April 6, 2019
      ✓ 
      Patent use: TREATMENT OF HIV




  • Crystal Forms of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
    Patent 6,639,071
    Issued: October 28, 2003
    Inventor(s): Louis S.; Crocker & Joseph L.; Kukura, II & Andrew S.; Thompson & Christine; Stelmach & Steven D.; Young
    Assignee(s): Merck & Co., Inc.
    The instant invention describes a method for crystallizing (−)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one from a solvent and anti-solvent system and producing the crystalline product. The desired final crystal form, Form I, can be produced when using methanol or ethanol. Form II is isolated from 2-propanol and can be converted to the desired crystal form at low drying temperatures, such as between about a temperature of 40° C. and 50° C.
    Patent expiration dates:

    • February 14, 2018
      ✓ 
      Drug substance




  • Crystal forms of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
    Patent 6,939,964
    Issued: September 6, 2005
    Inventor(s): Crocker; Louis S. & Kukura, II; Joseph L. & Thompson; Andrew S. & Stelmach; Christine & Young; Steven D.
    Assignee(s): Merck & Co., Inc.
    The instant invention describes a method for crystallizing (−)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one from a solvent and anti-solvent solvent system and producing the crystalline product. The desired final crystal form, Form I, can be produced when using methanol or ethanol. Form II is isolated from 2-propanol and can be converted to the desired crystal form at low drying temperatures, such as between about a temperature of 40° C. and 50° C.
    Patent expiration dates:

    • January 20, 2018
      ✓ 
      Drug substance



See also...

  • Sustiva Consumer Information (Drugs.com)
  • Sustiva Consumer Information (Wolters Kluwer)
  • Sustiva Consumer Information (Cerner Multum)
  • Sustiva Advanced Consumer Information (Micromedex)
  • Sustiva AHFS DI Monographs (ASHP)
  • Efavirenz Consumer Information (Wolters Kluwer)
  • Efavirenz Consumer Information (Cerner Multum)
  • Efavirenz Advanced Consumer Information (Micromedex)
  • Efavirenz AHFS DI Monographs (ASHP)

Genurin




Genurin may be available in the countries listed below.


Ingredient matches for Genurin



Flavoxate

Flavoxate hydrochloride (a derivative of Flavoxate) is reported as an ingredient of Genurin in the following countries:


  • China

  • Italy

  • Taiwan

  • Venezuela

  • Vietnam

International Drug Name Search

Saturday 3 October 2009

Sobiral




Sobiral may be available in the countries listed below.


Ingredient matches for Sobiral



Propafenone

Propafenone hydrochloride (a derivative of Propafenone) is reported as an ingredient of Sobiral in the following countries:


  • Japan

International Drug Name Search

Ebrantil




Ebrantil may be available in the countries listed below.


Ingredient matches for Ebrantil



Urapidil

Urapidil is reported as an ingredient of Ebrantil in the following countries:


  • Austria

  • Bosnia & Herzegowina

  • Croatia (Hrvatska)

  • Czech Republic

  • Germany

  • Hungary

  • Italy

  • Japan

  • Luxembourg

  • Netherlands

  • Poland

  • Serbia

  • Slovakia

  • Slovenia

Urapidil hydrochloride (a derivative of Urapidil) is reported as an ingredient of Ebrantil in the following countries:


  • Austria

  • Belgium

  • China

  • Croatia (Hrvatska)

  • Czech Republic

  • Georgia

  • Germany

  • Hungary

  • Luxembourg

  • Slovakia

  • Switzerland

International Drug Name Search

Thursday 1 October 2009

Sibutramina Colmed




Sibutramina Colmed may be available in the countries listed below.


Ingredient matches for Sibutramina Colmed



Sibutramine

Sibutramine hydrochloride monohydrate (a derivative of Sibutramine) is reported as an ingredient of Sibutramina Colmed in the following countries:


  • Colombia

International Drug Name Search